D;
docTLDR
India's 2-minute medical brief
August 14, 2025
15
Articles
3m 45s
Read Time
Today's Healthcare Brief
πDoctor Affairs & Legalβ’Adity, Medical Dialogues
LHMC doctors launch indefinite strike after mob assault on resident
A resident doctor at Lady Hardinge Medical College, New Delhi, was allegedly assaulted by a mob of a patient's relatives after a road accident case. The incident, captured on video and widely shared, has sparked outrage among the medical community. In response, the Resident Doctors Association has called an indefinite strike, suspending all elective services until the culprits are arrested and demands for improved security are met.
#healthcare#india#doctor-affairs-and-legal
Medical DialoguesRead Full β
πMedical Researchβ’Kristen Monaco
Emerging Gut Nutrient Shows Promise in Cancer Therapy
A newly identified gut-derived nutrient, indolepropionic acid (IPA), is gaining attention for its potential role in cancer prevention and therapy. Recent research highlights IPA's anti-inflammatory and antioxidant properties, suggesting it may help inhibit tumor growth and improve patient outcomes. Experts urge further clinical trials to validate its efficacy and explore integration into oncology protocols.
#healthcare#india#medical-research
MedscapeRead Full β
πDoctor Affairs & Legalβ’Not specified
Doctor assaulted at Mumbai hospital after denying patient admission
A 27-year-old man was booked for assaulting Dr. Sandip Kedar at Shatabdi Hospital, Govandi, after the doctor refused to admit his mother, citing her stable condition. The incident escalated when the man struck Dr. Kedar on the head with a blood pressure monitor, resulting in injuries. Police registered an FIR under the Maharashtra Medicare Service Persons and Medicare Service Institutions (Prevention of Violence and Damage or Loss to Property) Act.
#healthcare#india#doctor-affairs-and-legal
Free Press JournalRead Full β
π₯General Healthcare Newsβ’Shahid Akhter, FEHealthcare
Foreign Investment Fuels Hospital Tech, But Rural India Still Left Behind
Indiaβs healthcare sector has attracted $1.5 billion in foreign investment in FY24, mainly benefiting urban hospitals. Experts urge policy changes to incentivize private sector participation in government insurance schemes, aiming to reduce public hospital overload and improve rural access to advanced care.
#healthcare#india#general-healthcare-news
Financial Express HealthcareRead Full β
πClinical Updatesβ’Not specified
Liver function status predicts survival benefit in liver cancer therapy
Recent clinical evidence highlights that baseline liver function critically influences overall survival (OS) outcomes in hepatocellular carcinoma (HCC) patients receiving systemic therapies. Patients with better liver function (Child-Pugh A, ALBI score) experience superior OS and treatment response compared to those with impaired liver function. This underscores the need for regular hepatology assessment and tailored therapy selection to optimize outcomes in advanced HCC.
#healthcare#india#clinical-updates
MedscapeRead Full β
πMedical Researchβ’Not specified
New-onset diabetes signals sharply higher short-term pancreatic cancer risk
A recent study highlights that adults over 50 with new-onset diabetes face a 6β8-fold increased risk of developing pancreatic cancer within three years, with up to 1% diagnosed in this period. This association suggests new-onset diabetes may serve as an early warning sign, supporting targeted screening strategies to improve early pancreatic cancer detection and outcomes.
#healthcare#india#medical-research
Medical DialoguesRead Full β
πMedical Journalsβ’Rakesh Sarwal, NITI Aayog
India Faces $9.1 Billion GDP Loss from TB DeathsβWhy Urgent Action Is Needed
A new study quantifies the economic impact of tuberculosis-related deaths in India, revealing a staggering non-health GDP loss of US$9.1 billion in 2021. The highest burden falls on working-age adults, underscoring the urgent need for intensified TB control strategies and policy interventions to protect both public health and the economy.
#healthcare#india#medical-journals
PubMed CentralRead Full β
π§ͺMedical Technology & Devicesβ’Not specified
CDSCO Drafts New IVD Protocols: Indian Labs and Manufacturers Must Act by August 25
India's CDSCO and ICMR have released draft protocols for evaluating In-Vitro Diagnostics (IVDs), covering 15 disease types including dengue, malaria, and SARS-CoV-2. Stakeholders must submit feedback by August 25. Once finalized, these standards will directly impact licensing, device safety, and diagnostic accuracy for Indian labs and clinicians.
#healthcare#india#medical-technology-and-devices
ET HealthworldRead Full β
πPatient News Updatesβ’Not specified
Clinical guidelines for acute poisonings in low- and middle-income countries
A newly updated standard operating protocol for acute poisonings supports rapid clinical decision-making in emergency settings. Emphasizing five core principles, the guidelines are tailored for resource-limited environments, directly aiding Indian clinicians in improving outcomes for poisoning cases.
#healthcare#india#patient-news-updates
PubMedRead Full β
πPharmaceutical News & Updatesβ’EP News Bureau
Lillyβs Mounjaro KwikPen Launch Expands Diabetes and Obesity Treatment Options in India
Eli Lilly has launched Mounjaro KwikPen (tirzepatide) in India, a once-weekly injectable dual GIP/GLP-1 agonist for type 2 diabetes and chronic weight management. Available in six strengths, the pen allows for personalized dosing. Approved by CDSCO, it offers a new, convenient option for Indian clinicians managing diabetes and obesity.
#healthcare#india#pharmaceutical-news-and-updates
Express PharmaRead Full β
πClinical Updatesβ’Not specified
Liraglutide plus keto diet delivers superior obesity weight loss
Combining liraglutide, a GLP-1 receptor agonist, with a very low-calorie ketogenic diet (VLCKD) yields synergistic effects for obesity treatment. Real-world clinical data show this dual approach leads to greater and faster weight loss than either intervention alone, with improved metabolic parameters and visceral fat reduction. The combination is well-tolerated and may offer a promising strategy for patients with obesity, including those with type 2 diabetes, seeking intensified weight manage...
#healthcare#india#clinical-updates
MedscapeRead Full β
πClinical Updatesβ’Wei Lin, Sichuan University
High-concentration arginine toothpaste cuts childhood caries by 26% in major trial
A two-year, multicenter randomized trial in 6,000 children (aged 10β14) found that toothpaste with 8.0% arginine reduced dental caries by 26% (DMFS) and 25.3% (DMFT) compared to standard sodium fluoride toothpaste. Lower arginine concentration (1.5%) showed no significant difference from fluoride. This study positions high-concentration arginine dentifrice as an effective alternative or adjunct to fluoride for caries prevention in children with active caries.
#healthcare#india#clinical-updates
News MedicalRead Full β
πHealthcare Infrastructure & Failuresβ’Not specified
AIIMS faces major faculty exodus: 429 resign in 3 years, 1 in 3 posts vacant
Between 2022 and 2024, 429 faculty members resigned from various AIIMS across India, including 52 from AIIMS Delhi, as revealed in Parliament. The resignations, driven by both personal and professional factors, have left nearly one-third of faculty positions vacant nationwide. This exodus threatens teaching, research, and patient care quality at India's premier public hospitals.
#healthcare#india#healthcare-infrastructure-and-failures
Medical DialoguesRead Full β
πMedical Researchβ’Not specified
Stroke disrupts brain pathways for word meaning in reading
A new study reveals that stroke impairs reading by disrupting specific brain pathways responsible for processing word meanings. Researchers found that damage to left hemisphere cortical areas and their connecting white matter tracts significantly affects comprehension of complex sentence structures. This nuanced understanding highlights the importance of targeted rehabilitation strategies for post-stroke language recovery, emphasizing that not all sentence types are equally affected.
#healthcare#india#medical-research
News-Medical.netRead Full β
πMedical Researchβ’Not specified
Ticagrelor, Prasugrel Match Clopidogrel for 1-Year Mortality in STEMI with Severe CKD
A recent study found that in STEMI patients with severe chronic kidney disease (CKD), ticagrelor and prasugrel were as effective as clopidogrel in reducing 1-year all-cause mortality after percutaneous coronary intervention (PCI). The findings suggest that newer P2Y12 inhibitors do not confer additional survival benefit over clopidogrel in this high-risk group, supporting current guideline recommendations for individualized antiplatelet therapy in severe CKD.
#healthcare#india#medical-research
Medical DialoguesRead Full β
Stay Updated with docTLDR
Get tomorrow's medical brief delivered to your inbox at 7 AM IST. Join 1000+ Indian doctors who trust us for their daily healthcare updates.